BURRELL INTERNATIONAL GROUP LLC

Lobbying for BIOFACTURA, INC. · Biopharmaceutical industry development, scale-up, and manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $10,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Medical Countermeasure Development for Smallpox and FY26 LHHS Appropriation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.